Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

BrainBaseline Assessment of Cognition and Everyday Functioning ("BRACE"-ing for the Future): Establishing iPad-Based Norms for Cognitive Function in the Multicenter AIDS Cohort Study and Women's Interagency HIV Study Combined Cohort Study.

JMIR mental health·2026
Same author

Validation of remote multimodal AI screening for Parkinson disease across diverse settings.

Communications medicine·2026
Same author

Morphable architected materials with topologically variable and volumetric reconfiguration.

Materials horizons·2026
Same author

Digital Technologies for Symptom Monitoring in Parkinson Disease.

Current neurology and neuroscience reports·2026
Same author

Three years later: tracking bothersome symptoms and impacts for people with early Parkinson's disease.

Journal of neurology·2026

Related Experiment Video

Updated: Jun 17, 2026

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.7K

Wearable Sensor-Based Assessments for Remotely Screening Early-Stage Parkinson's Disease.

Shane Johnson1, Michalis Kantartjis1, Joan Severson1

  • 1Clinical Ink, Winston-Salem, NC 27101, USA.

Sensors (Basel, Switzerland)
|September 14, 2024
PubMed
Summary

Wearable sensors can accurately screen for Parkinson's disease (PD), a growing neurodegenerative condition. This technology bridges the gap between symptoms and diagnosis, improving early detection for Parkinson's disease.

Keywords:
Parkinson’s diseasedigital biomarkersearly detectionfeature engineeringgait analysismobile health technologiesphonationremote monitoringwearable sensors

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.1K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.8K

Related Experiment Videos

Last Updated: Jun 17, 2026

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.7K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.1K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.8K

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Digital Health

Background:

  • Parkinson's disease (PD) prevalence is underestimated due to diagnostic challenges and limited screening.
  • Wearable devices offer objective, frequent monitoring of PD symptoms.
  • Early detection of PD is crucial for effective management and intervention.

Purpose of the Study:

  • To develop and validate a Parkinson's disease screening tool using consumer-grade wearable sensor data.
  • To address the gap between symptom onset and formal PD diagnosis.
  • To leverage machine learning for accurate early-stage PD detection.

Main Methods:

  • Utilized data from the WATCH-PD study, including consumer-grade wearable devices and sensors.
  • Engineered features relevant to Parkinson's disease motor and non-motor symptoms.
  • Applied multivariate machine learning, specifically a random forest model, to classify early-stage PD status.

Main Results:

  • Developed a highly accurate (92.3%) random forest classification model for early-stage PD detection.
  • Achieved high sensitivity (90.0%) and specificity (100%) in PD screening.
  • Demonstrated robust performance across different environments and platforms (AUC = 0.92).

Conclusions:

  • Consumer-grade wearable devices and sensors show significant potential for population-wide Parkinson's disease screening.
  • This approach can improve early diagnosis and surveillance of Parkinson's disease.
  • Further research into wearable technology for PD screening is warranted.